Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ORIFARM A/S
A/S
Active
Advertising protection
CVR 26058708
Energivej 15, 5260
Odense S
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2001 · 25 years old
40 employees
Monitor
Share
Denmark
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
ORIFARM A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
DKK millions
0M
453M
906M
1B
2B
1.5B
2021
1.4B
2022
1.6B
2023
1.2B
2024
1.2B
2025
EBITDA
DKK millions
25M
19M
13M
6M
0M
19M
2021
18M
-5%
2022
20M
+11%
2023
20M
0%
2024
19M
-5%
2025
Income statement
DKK thousands
Item
2021
2022
2023
2024
2025
Revenue
1.493.622
1.404.798
1.575.946
1.223.777
1.174.659
Staff expenses
-415
-2.036
-7.494
-3.267
-4.396
EBITDA
19.075
18.119
20.141
19.964
18.622
Depreciation & amort.
-4.979
-4.072
-4.379
-4.669
-4.415
EBIT
14.096
14.047
15.762
15.295
14.207
Net financials
-3.076
-830
8.094
3.706
-1.549
Profit before tax
11.020
13.217
23.856
19.001
12.658
Tax
2.830
3.276
4.982
4.136
2.931
Net profit
8.190
9.941
18.874
14.865
9.727
Balance sheet
DKK thousands
Item
2021
2022
2023
2024
2025
Total assets
195.390
421.634
301.842
150.368
148.121
Equity
47.442
57.382
76.256
53.921
44.048
Long-term debt
0
0
0
0
0
Short-term debt
145.810
362.313
223.571
94.065
102.063
Total debt
145.810
362.313
223.571
94.065
102.063
Financial ratios
5-year trend
EBITDA margin
1.6%
This company
15.8%
Market median
-90% vs market
2021
2025
Equity ratio
29.7%
This company
38.2%
Market median
-22% vs market
2021
2025
Return on equity
22.1%
This company
18.4%
Market median
+20% vs market
2021
2025
Net profit margin
0.8%
This company
8.1%
Market median
-90% vs market
2021
2025
Asset turnover
7.93×
This company
1.12×
Market median
+608% vs market
2021
2025
Debt / equity
2.36×
This company
0.62×
Market median
-281% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on ORIFARM A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
